Trial intelligence / Profile preview

Remifentanil and Alfentanil for Emergence Agitation in Pediatric Ophthalmic Surgery

NCT02486926Completed

Sponsor
Hallym University Medical Center
Start
Nov 2012
Primary completion
Jul 2013
Modality
Orthosteric Ligands
01

Overview

Randomised trial of remifentanil and alfentanil in Emergence agitation (EA) (3 arms), sponsored by Hallym University Medical Center. Primary endpoint: Incidence of Emergence Agitation. Started Nov 2012; status: completed.

02

Drugs

remifentanilalfentanil
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT02486926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02486926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call